Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$2.34 - $5.31 $4.87 Million - $11.1 Million
-2,081,077 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$1.89 - $8.53 $2.83 Million - $12.8 Million
-1,498,300 Reduced 41.86%
2,081,077 $10.1 Million
Q2 2021

Aug 16, 2021

BUY
$2.46 - $3.14 $8.81 Million - $11.2 Million
3,579,377 New
3,579,377 $9.56 Million
Q3 2020

Nov 16, 2020

SELL
$2.6 - $5.37 $1.92 Million - $3.96 Million
-737,612 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$2.56 - $5.44 $1.89 Million - $4.01 Million
737,612 New
737,612 $4.01 Million
Q1 2019

May 15, 2019

SELL
$3.75 - $4.97 $1.11 Million - $1.47 Million
-295,420 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$3.29 - $8.94 $184,177 - $500,470
-55,981 Reduced 15.93%
295,420 $1.08 Million
Q3 2018

Nov 14, 2018

SELL
$8.58 - $11.4 $849,411 - $1.13 Million
-98,999 Reduced 21.98%
351,401 $3.02 Million
Q2 2018

Aug 14, 2018

SELL
$9.42 - $13.73 $181,806 - $264,989
-19,300 Reduced 4.11%
450,400 $4.95 Million
Q1 2018

May 15, 2018

SELL
$7.48 - $11.53 $888,115 - $1.37 Million
-118,732 Reduced 20.18%
469,700 $5.42 Million
Q4 2017

Feb 14, 2018

SELL
$9.3 - $16.93 $2.98 Million - $5.42 Million
-320,093 Reduced 35.23%
588,432 $6.1 Million
Q3 2017

Nov 14, 2017

BUY
$11.3 - $17.23 $10.3 Million - $15.7 Million
908,525
908,525 $14.5 Million

Others Institutions Holding CRVS

About Corvus Pharmaceuticals, Inc.


  • Ticker CRVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,553,500
  • Market Cap $379M
  • Description
  • Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase Ib/II clinical trial for non-small cell lung cancer and head and neck cancers. The compan...
More about CRVS
Track This Portfolio

Track Eco R1 Capital, LLC Portfolio

Follow Eco R1 Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eco R1 Capital, LLC with notifications on news.